• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. Little data exists about how to get adhd medication without diagnosis long-term exposure to these medications may affect the foetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking adhd focus medication (marsh-Gibson-3.Technetbloggers.de) medication need to evaluate the benefits of using it versus the risks for the baby. Physicians do not have the data needed to provide clear recommendations however they can provide information about benefits and risks that can help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers used a vast population-based study of case-control to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists examined the cases to ensure accurate classification of the cases and to reduce the chance of bias.

However, the researchers' study had its limitations. In particular, they were unable to distinguish the effects of the medication from those of the disorder that is underlying. This makes it difficult for researchers to determine if the small differences observed between the groups exposed were due to medication use, or if they were affected by the presence of comorbidities. The researchers did not look at long-term outcomes for the offspring.

The study did find that infants whose mothers took ADHD medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had cut back on their medications prior to or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These increases didn't seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the small risks associated with the use inattentive adhd medication adults medications in early pregnancies may be offset by the greater benefits for baby and mother of continued treatment for the woman's disorder. Physicians should talk to their patients about this issue and as much as possible, assist them develop coping skills that can lessen the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the dilemma of whether or not to end treatment during pregnancy is one that more and more physicians have to face. The majority of these decisions are made without any evidence that is clear and definitive either way, so physicians must weigh their knowledge, the experiences of other doctors, and what research suggests on the subject as well as their own best judgment for each individual patient.

The issue of possible risks to the infant can be extremely difficult. The research on this issue is based on observation rather than controlled studies and many of the findings are in conflict. In addition, most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could result in abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion: While some studies have shown an association between ADHD medications and the possibility of certain birth defects, others have not found any evidence of a link, and most studies demonstrate a neutral or slightly negative impact. In the end an accurate risk-benefit analysis must be conducted in every situation.

For many women with ADHD and ADD, the decision to stop medication is difficult, if not impossible. In fact, in an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of isolation and family conflict for those suffering from the disorder. A loss of medication may also impact the ability to drive safely and complete work-related tasks, which are vital aspects of normal life for those with ADHD.

She suggests that women who are not sure whether to take the medication or stop due to pregnancy should educate family members, colleagues, and their friends about the condition, its effects on daily functioning, and the benefits of keeping the current treatment. It can also make the woman feel more comfortable when she is struggling with her decision. Some medications can pass through the placenta. If a patient decides to not take her ADHD medication while breastfeeding, it is important to be aware that the medication could be transferred to the baby.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about the effects that the drugs might have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this topic. Researchers used two huge data sets to study more than 4.3 million pregnancies and determine if the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with an increase in the risk of specific heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study didn't find any association between early medication usage and other congenital anomalies such as facial deformities or club feet. The findings are in line with previous studies that have shown a small but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of the birth of their child. The risk was higher during the latter part of pregnancy, as many women begin to discontinue their adhd medication ritalin medication.

Women who took ADHD medication in the first trimester of their pregnancies were also more likely to experience caesarean section, low Apgar score after delivery and a baby who required breathing assistance during birth. However, the authors of the study were not able to eliminate selection bias by restricting the study to women who did not have other medical issues that could have contributed to these findings.

Researchers hope that their study will help doctors when they meet pregnant women. The researchers advise that, while discussing benefits and risks are crucial, the decision on whether to continue or stop taking medication should be based on the severity of each woman's ADHD symptoms and her needs.

The authors warn that, even though stopping the medication is an option to look into, it is not advised because of the high incidence of depression and mental health issues among women who are pregnant or recently gave birth. Additionally, the research suggests that women who decide to stop their medications are more likely to have difficulties adjusting to life without them after the baby's arrival.

Nursing

The responsibilities of a new mom can be overwhelming. Women with ADHD who must work through their symptoms while attending physician appointments as well as getting ready for the arrival of a baby and adjusting to new household routines are often faced with a number of difficulties. Many women choose to continue taking their adhd inattentive type medication medication during pregnancy.

The majority of stimulant medicines are absorbed through breast milk in small quantities, so the risk to the breastfeeding infant is minimal. The amount of exposure to medications will differ based on dosage the medication is administered, its frequency and the time of the day. In addition, different medications enter the baby’s system through the gastrointestinal tract or breast milk. The impact of these medications on a newborn's health is not completely understood.

Due to the absence of research, some physicians may be inclined to discontinue stimulant drugs during a woman's pregnancy. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the possible dangers to the foetus. In the meantime, until more information is available, GPs may ask pregnant patients if they have a history of adhd and depression medication or if they are planning to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue to take their ADHD medication without risk during pregnancy and while breast-feeding. This has led to many patients opt to do this and, in consultation with their doctor they have found that the benefits of continuing their current medication outweigh any potential risks.

Women who suffer from ADHD who are planning to breastfeed should seek the advice of an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help pregnant people with ADHD understand their symptoms and the root cause and learn about treatment options and reinforce existing coping strategies. This should include a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counselling should include the discussion of a treatment plan for both the mother and child, and monitoring for signs of deterioration, and the need for adjustments to the medication regimen.